Sr. Manager, Strategy - Oncology & Multispecialty

McKesson•Irving, TX

25d•Hybrid

About The Position

The Sr. Manager, Strategy – Oncology & Multispecialty is an analytical individual contributor role within the strategy team, supporting the development of frameworks, models, and research that enable the evaluation and execution of key strategic initiatives. Initiatives span both commercial segments — provider-facing (GPO, specialty distribution, specialty pharmacy, alternate site infusion, practice management) and biopharma-facing (clinical trial site management, real-world evidence, clinicogenomic data) — and frequently sit at the intersection between the two, where the segment’s most distinctive strategic questions live. The Sr. Manager will be expected to independently and comprehensively develop an analytical model that supports each initiative and complete required analysis and research required to enable leadership to make informed decisions and develop a path forward. Taking responsibility for accuracy and completeness, the senior manager will be expected to bring their own thoughts and perspectives to the analytical process to ensure effective evaluation of initiatives.

Requirements

4+ years of progressive experience in strategy consulting, corporate strategy, investment banking, private equity, or comparable analytically intensive roles.
Exposure to healthcare services, specialty care, life sciences, or health data businesses strongly preferred; genuine interest in the economics of oncology and specialty care is essential.
Demonstrated advanced financial modeling capability — building models from a blank sheet that connect market dynamics to P&L outcomes.
Track record of structuring ambiguous problems, executing rigorous analysis, and producing executive-ready synthesis and deliverables.
Experience working effectively in cross-functional teams and managing multiple deliverables under time pressure.

Nice To Haves

Structured Problem Solver: Formulates clear hypotheses and structures workstreams well with light guidance; handles complex analyses with little oversight and moves efficiently from data to insight.
Financial Modeling & P&L Literacy: Builds financial models as strategic tools — not to forecast with false precision but to identify the assumptions that matter and quantify the implications of strategic choices.
Synthesis & Storytelling: Distills complex information into clear, logical storylines; writes and charts at near executive-ready quality; consistently answers “so what.”
Specialty Care Curiosity: Demonstrates genuine intellectual curiosity about how practice economics, specialty distribution and pharmacy, and biopharma services actually work — and is building working fluency in them.
Collaborative Teammate: Is a reliable, helpful, and proactive teammate; builds trust with partners across the business; coaches junior colleagues and is open to coaching from others.
Communication: Writes clearly and concisely; presents with confidence in familiar settings; listens well and tailors style and tone to the audience.

Responsibilities

Own end-to-end analytical workstreams within larger strategic initiatives — from problem structuring and hypothesis development through analysis and synthesis of findings — with guidance from initiative leads.
Build rigorous fact bases including on market structure and trending, competitor strategies and economics, practice and provider segmentation, commercialization opportunities, and biopharma demand across both the provider-facing and biopharma-facing franchises.
Synthesize complex quantitative and qualitative information into clear, well-structured storylines; consistently deliver the “so what,” not just the analysis.
Identify implications of your own workstream for the overall initiative, and flag issues and opportunities to initiative leadership proactively.
Build and maintain financial models that translate market shifts — reimbursement changes, biosimilar entry, site-of-care dynamics, practice consolidation, biopharma R&D spending shifts — into quantified P&L implications, with review from senior team members.
Develop working knowledge of how participants in the specialty care value chain — biopharma manufacturers, GPOs, distributors, specialty pharmacies, payers, providers, CROs, and RWE and data companies — earn and protect economic value.
Track and analyze regulatory and policy developments — 340B reform, Medicare Part B drug reimbursement, oncology care model evolution, FDA policy on real-world evidence as examples — and support the assessment of their implications.
Support scenario and sensitivity analysis: pressure-test the assumptions that matter most and help bound the range of plausible outcomes.
Participate actively in team problem solving; step up to lead portions of problem-solving sessions with the team and with business partners.
Challenge assumptions constructively and take intellectual risks to generate new ideas; bring curiosity about how community care, specialty pharmacy, and biopharma services actually work economically.
Manage your own time and workplan effectively; know how and when to seek input; control the quality of your own work product.
Prepare well-written, logical, concise documents and executive materials with minimal guidance; lead with key messages.
Present analysis and recommendations with clarity to initiative teams and, with preparation, to senior business audiences.
Build collaborative working relationships with business, finance, clinical, and functional partners across both franchises; project credibility and reliability.
Coach analysts and newer team members on analytical craft, modeling standards, and story-lining; provide constructive upward feedback.
Contribute to strategy function-building efforts — recruiting, knowledge capture, analytical tooling, and ways of working.